Platomics

Platomics

Vienna, Austria· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3M

Overview

Platomics operates at the intersection of AI/ML, genomics, and regulatory science, providing a software-as-a-service platform to streamline IVD compliance. Its core offering, the PlatoX® regulatory platform, helps labs and manufacturers efficiently generate the documentation required under regulations like the IVDR. By digitizing and automating these burdensome processes, Platomics aims to reduce compliance costs, prevent a reduction in diagnostic offerings, and ultimately speed up the delivery of advanced tests to patients. The company is ISO 13485 and 27001 certified, underscoring its commitment to quality and data security in the healthcare sector.

AI / Machine LearningGenetics & Genomics

Technology Platform

PlatoX® regulatory platform: A software platform that automates and digitizes the generation of technical documentation and compliance workflows for in vitro diagnostics (IVD) under regulations like the EU IVDR.

Funding History

2
Total raised:$3M
Grant$500K
Seed$2.5M

Opportunities

The stringent and complex EU IVDR has created a large, immediate market of diagnostic manufacturers and labs needing compliance solutions.
Expansion into other regulated regions (e.g., the US, if LDT regulations change) and vertical expansion into related regulatory workflows (e.g., for medical devices) present significant growth avenues.

Risk Factors

The business is highly dependent on the continuation of complex IVD regulations; significant regulatory simplification could reduce demand.
The company also faces competition from consulting firms and other software providers, and must overcome the slow adoption cycles typical of healthcare institutions.

Competitive Landscape

Platomics competes in the regulatory technology (RegTech) niche for diagnostics. Competitors likely include large regulatory consulting firms (e.g., Emergo by UL, NSF) offering manual services and potentially developing software tools, as well as other specialized SaaS startups focusing on medical device or IVD compliance. Its differentiator is a dedicated platform combining software automation with targeted educational content for the IVD sector.